Press release
Myelofibrosis Clinical Trial Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Download DelveInsight's comprehensive Myelofibrosis Pipeline Report to explore emerging therapies, key Companies, and future treatment landscapes @ https://www.delveinsight.com/sample-request/myelofibrosis-pipeline-insight [https://www.delveinsight.com/sample-request/myelofibrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Myelofibrosis Pipeline Report
* On January 23, 2026- Disc Medicine Inc. initiated a phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofibrosis or myelodysplastic syndrome and anemia.
* On January 20, 2026- AbbVie announced a Phase 2 open-label, multicenter study evaluating tolerability and efficacy of navitoclax alone or when added to ruxolitinib in participants with myelofibrosis.
* On January 16, 2026- iOnctura clinical trial is to learn how roginolisib works in comparison to standard treatment in adult patients with Myelofibrosis. The main questions it aims to answer is to evaluate the safety and tolerability of roginolisib when administered in combination with ruxolitinib.
* On January 09, 2026- Swedish Orphan Biovitrum conducted a study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in patients with MF and severe thrombocytopenia (platelet count
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myelofibrosis Clinical Trial Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight here
News-ID: 4373935 • Views: …
More Releases from ABNewswire
MT Dunn Plumbing Expands Emergency Services in Hillsboro & Across Portland, Oreg …
MT Dunn Plumbing LLC (CCB# 234243) expands 24/7 emergency services across Hillsboro, Beaverton, Portland & Washington County. The licensed, bonded, and insured contractor provides immediate response for burst pipes, water heater failures, sewer backups, and drain clogs. Operating from Hillsboro, owner Michael T Dunn serves residential and commercial properties region-wide. Emergency contact: 503-640-2458 or mtdunnplumbing.com.
Hillsboro, OR - MT Dunn Plumbing LLC, a licensed and established plumbing contractor serving the Portland…
Beyond the Prompt: How Mimic Motion Architecture is Redefining the 2026 Passive …
Image: https://www.abnewswire.com/upload/2026/02/ac57e1a7b6e53a95f52ea0f18fcb990c.jpg
As we move through 2026, the digital economy is no longer just about "what" you show, but "how" it moves. Static content is losing ground to kinetic, motion-driven narratives that capture attention in seconds. At the center of this shift is Loova, whose proprietary Mimic Motion architecture has become the secret engine behind some of the most successful passive income streams this year.
This report breaks down the technical logic…
The Real Cost of Convenience: A Complete Guide to Vending Machine Startup Costs
Image: https://www.abnewswire.com/upload/2026/02/32ec9ac40420df59e70c21070d981def.jpg
The dream of earning passive income often leads aspiring entrepreneurs to the world of automated retail. It is a sector defined by low labor requirements and the ability to generate revenue around the clock. However, before you can stock your first row of snacks, you must understand the financial commitment required to get your equipment on-site. Many beginners find themselves asking how much do vending machines cost [https://dfyvending.com/vending-machine-startup-costs] as…
Benji Personal Injury Surpasses 1,000 Cases Won as California Accident Victims S …
Benji Personal Injury Accident Attorneys, A.P.C. has surpassed 1,000 personal injury cases resolved across California, reflecting a growing demand for trialready legal representation. The firm's litigationfirst approach has led to multimilliondollar verdicts and settlements, helping accident victims secure significantly higher compensation through courtroomfocused preparation.
LOS ANGELES, CA - Benji Personal Injury Accident Attorneys, A.P.C. announced today that the firm has successfully resolved over 1,000 personal injury cases, marking a significant milestone…
More Releases for Myelofibrosis
Primary Myelofibrosis (PMF) Market Insights and Future Outlook
Introduction
Primary myelofibrosis (PMF) is a rare, chronic myeloproliferative neoplasm characterized by progressive bone marrow fibrosis, splenomegaly, anemia, and systemic symptoms such as fatigue, night sweats, and weight loss. Unlike secondary myelofibrosis, which arises from other blood cancers, PMF develops as a distinct disease entity, typically driven by mutations in JAK2, CALR, or MPL genes.
PMF has long been associated with poor prognosis and limited therapeutic options. Historically, treatment focused on symptom…
Myelofibrosis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Myelofibrosis Pipeline Insight 2024" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Myelofibrosis Research. Learn more about our innovative…
Secondary Myelofibrosis Therapeutics Market - Revolutionizing Treatment for Seco …
Newark, New Castle, USA: The "Secondary Myelofibrosis Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Secondary Myelofibrosis Therapeutics Market: https://www.growthplusreports.com/report/secondary-myelofibrosis-therapeutics-market/8885
This latest report researches the industry structure,…
Myelofibrosis Market - Transforming Challenges into Triumphs: Myelofibrosis Mark …
Newark, New Castle, USA: The "Myelofibrosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Myelofibrosis Market: https://www.growthplusreports.com/report/myelofibrosis-market/8802
This latest report researches the industry structure, sales, revenue, price and…
Secondary Myelofibrosis Therapeutics Market - Unleashing Resilience, Defying Mye …
Newark, New Castle, USA - new report, titled Secondary Myelofibrosis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Secondary Myelofibrosis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Secondary Myelofibrosis Therapeutics market. The report offers an overview of…
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,…
